Erudio Healtherudio.com
Drug
Talazoparib trials: what clinicians said in public
No HCP commentary report on a trial studying talazoparib yet. Erudio has found public clinician commentary on 9 clinical trials studying talazoparib, including EMBRACA, ROME, TALAPRO-1 and TAPUR. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| TAPUR NCT02693535 · American Society of Clinical Oncology DeepView → | advanced solid tumors, non-Hodgkin lymphoma or multiple myeloma | Phase 2 | Deep | View | |||
| EMBRACA NCT01945775 · Pfizer DeepView → | germline BRCA-mutated locally advanced or metastatic breast cancer | Phase 3 | Deep | View | |||
| ROME NCT04591431 · Fondazione per la Medicina Personalizzata DeepView → | advanced solid tumors | Phase 2 | Deep | View | |||
| TALAPRO-1 NCT03148795 · Pfizer DeepView → | metastatic castration-resistant prostate cancer with DNA repair alterations | Phase 2 | Deep | View | |||
| TALAPRO-3 NCT04821622 · Pfizer StandardView → | DDR gene-mutated metastatic castration-sensitive prostate cancer | Phase 3 | Standard | View | |||
| PERSEVERE NCT04849364 · Bryan Schneider, MD StandardView → | residual triple negative breast cancer | Phase 2 | Standard | View | |||
| S1900C NCT04173507 · SWOG Cancer Research Network FocusedView → | Not given | Phase 2 | Focused | View | |||
| S1929 NCT04334941 · National Cancer Institute (NCI) FocusedView → | SLFN11-positive extensive-stage small cell lung cancer | Phase 2 | Focused | View | |||
| TRESR NCT04497116 · Repare Therapeutics FocusedView → | Not given | Phase 1/Phase 2 | Focused | View | |||